Trump administration finalizes rule overhauling health insurer price transparency requirements

On October 5, 2026, the Trump administration finalized a major overhaul of the 'Transparency in Coverage' rules, requiring health insurers to standardize pricing files, eliminate 'ghost rates,' and allow consumers to request cost estimates over the phone. While the changes are projected to save insurers $175 million annually after initial implementation, they face $400 million in one-time compliance costs. Additionally, officials announced a timeline to finalize prescription drug price disclosures by May 2027.

Transparency in Coverage rule overhaul

• ▪The updated price transparency rule is estimated to generate nearly $175 million in annual net cost savings for plans and issuers after the first year, despite $400 million in one-time compliance costs.
• ▪On October 5, 2026, the Trump administration finalized a rule overhauling the "Transparency in Coverage" regulations to make health insurer price disclosures clearer and more usable.
• ▪The final rule overhauling health insurer price transparency was issued jointly on October 5, 2026, by the Department of Health and Human Services, the Department of Labor, and the Department of the Treasury.

Data standardization requirements

• ▪The finalized price transparency rule requires health insurers to standardize pricing files, report in-network rates as dollar figures rather than percentages, and transition from monthly to quarterly reporting.
• ▪The October 5, 2026, price transparency rule requires health insurers to report negotiated rates by provider network rather than by individual plan or policy to reduce file sizes.
• ▪Under the October 5, 2026, price transparency rule, health insurers must aggregate out-of-network price data by insurance market and lower the reporting threshold for out-of-network care from 20 claims to 11 claims.
• ▪The October 5, 2026, price transparency rule requires health insurers to have a senior executive, such as the CEO, certify that the published pricing files are accurate and complete.

Ghost rate elimination

• ▪Under the October 5, 2026, price transparency rule, insurers are permitted to use internal rules to exclude certain provider-service combinations from disclosures, provided they explain the exclusions in an attached file.
• ▪The finalized price transparency rule mandates that health insurers eliminate "ghost rates," which are negotiated rates for medical services that a provider would never actually perform.

Consumer cost comparison benefits

• ▪The finalized price transparency rule requires health insurers to make pricing information available to consumers over the telephone, in addition to online or paper formats.
• ▪Health and Human Services Secretary Robert F. Kennedy Jr. stated on October 5, 2026, that the new price transparency rules will reduce pricing data file sizes by 70 percent.

Prescription drug price disclosure timeline

• ▪The Trump administration announced plans to begin developing a prescription drug pricing file schema in November 2026, with a final plan expected by May 2027.
• ▪The federal government plans to enforce the new prescription drug price disclosure requirements by the end of 2027.

Hospital compliance enforcement

• ▪A September 2026 report by Patient Rights Advocate found that only 49.4 percent of surveyed hospitals were in full compliance with the initial hospital price transparency rules.
• ▪Federal Trade Commission Chairman Andrew Ferguson issued a formal warning on October 5, 2026, to major for-profit hospital groups regarding their legal obligation to provide truthful pricing.

Debatable claims

• ▪The complexity of healthcare pricing disclosures will overwhelm average consumers
• ▪Healthcare price transparency rules will lower medical costs for consumers
• ▪The long-term savings of the price transparency rule justify its high initial compliance costs
• ▪Requiring health insurance executives to certify pricing data accuracy is an appropriate accountability measure